MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

PTC Therapeutics Company Profile (NASDAQ:PTCT)

Consensus Ratings for PTC Therapeutics (NASDAQ:PTCT) (?)
Ratings Breakdown: 1 Hold Rating(s), 10 Buy Rating(s)
Consensus Rating:Buy (Score: 2.91)
Consensus Price Target: $93.70 (145.35% upside)

Current Analysts' Coverage Summary for PTC Therapeutics (NASDAQ:PTCT)
Show:
DateFirmActionRatingPrice TargetActions
8/25/2015Citigroup Inc.Initiated CoverageBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/23/2015Roth CapitalReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015RBC CapitalBoost Price TargetOutperform$81.00 -> $85.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2015JPMorgan Chase & Co.UpgradeNeutral -> Overweight$74.00 -> $100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015OppenheimerSet Price TargetBuy$155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2015Deutsche BankReiterated RatingBuy$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Credit SuisseReiterated RatingOutperform$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015Cowen and CompanyUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015BarclaysInitiated CoverageOverweight$100.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015WedbushBoost Price Target$81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2014Bank of AmericaReiterated RatingBuy$50.00 -> $48.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014B. RileyInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2013Evercore ISIBoost Price TargetOverweight$30.00 -> $34.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha